KYNB — KYNTRA BIO, INC.

—
Nasdaq · Health Care · Pharmaceuticals · CIK 921299 ·
Last close
$2.04
Market Cap
$8.26M
52W High
$10.47
52W Low
$2.00
ADV30
31,011
Next earnings
2026-11-16

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGross profitOp incomeNet incomeAssetsCashLiabilities
Sep 2026 1,762,000 1,143,000 -12,880,000 157,000 48,851,000 9,905,000 56,041,000
Jun 2026 -1,474,000 -1,476,000 -17,563,000 11,974,000 101,078,000 50,644,000 109,222,000
Mar 2026 3,738,000 -368,000 -13,796,000 -15,198,000 109,629,000 36,997,000 118,919,000
Dec 2025 1,277,000 999,000 -13,519,000 -14,220,000 119,594,000 47,872,000 115,119,000

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$-38,053,000
Investing CF
$56,139,000
Financing CF
$-85,943,000
CapEx
$-38,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$45.30
As of
2026-11-15

Balance + Analyst (yfinance extras)

Retained Earnings
$-1,709,271,000
Inventory
$3,384,000
Receivables
$347,000
ST Investments
$40,674,000
EBIT TTM
$-21,624,000
Pretax Income TTM
$-30,915,000
Interest Exp TTM
$9,291,000
Analysts
4

Yahoo Snapshot (yfinance, live)

Total Revenue
$4,616,000
EBITDA
$-50,035,000
Free Cash Flow
$54,074,376
Enterprise Value
$-37,046,480
Total Cash
$91,318,000
Total Debt
$0
Shares Out
4,049,124
Trailing EPS
$-7.64
Book Value
$-7.45
ROE
—
ROA
-22.5%
Div Yield
—

Annual Trend (SEC EDGAR, last 4y)

Revenues vs Net Income (last 4y)

FY endRevenuesOp incomeNet incomeAssetsLiabilitiesEquityOp cash flow
Dec 2025 6,440,000 -45,342,000 183,452,000 119,594,000 115,119,000 -30,038,000 -4,774,000
Dec 2024 29,621,000 -130,962,000 -47,579,000 214,525,000 398,160,000 -225,602,000 -137,999,000
Dec 2023 46,803,000 -310,115,000 -284,232,000 423,529,000 585,728,000 -204,166,000 -315,021,000
Dec 2022 140,734,000 -301,025,000 -293,654,000 610,087,000 611,567,000 -21,447,000 -145,933,000

TTM Snapshot

Revenues TTM
$4,617,000
NetIncome TTM
$183,192,000
OpCashFlow TTM
—
Assets (Latest)
$101,078,000
Forward EPS
$-14.23

Peers — same industry

TickerNameMarket CapLastDaily %
MTVA MetaVia Inc. $8.24M $1.25 —
VTGN Vistagen Therapeutics, Inc. $8.34M $0.19 —
AEMD AETHLON MEDICAL INC $8.17M $5.08 —
CALC CalciMedica, Inc. $8.41M $1.22 —
DARE Dare Bioscience, Inc. $8.44M $0.43 —

News headlines (Yahoo Finance, 1h cache)

Kyntra Bio (KYNB) Q3 2026 Earnings Call Transcript
2026-11-17 17:17 · Yahoo
Kyntra Bio (KYNB) Reports Q3 Loss, Misses Revenue Estimates
2026-11-16 22:15 · Yahoo
Kyntra Bio: Q3 Earnings Snapshot
2026-11-16 22:11 · Yahoo
Kyntra Bio Reports Third Quarter 2026 Financial Results and Provides Business Update
2026-11-16 21:05 · Yahoo
Kyntra Bio to Report Third Quarter 2026 Financial Results
2026-11-13 13:30 · Yahoo
Kyntra Bio Appoints Andrew E. Singer, MBA to its Board of Directors
2026-10-01 11:00 · Yahoo
Kyntra Bio to Present at the H.C. Wainwright 28th Annual Global Investment Conference
2026-09-02 11:30 · Yahoo
Kyntra Bio Continues Balance Sheet Transformation with Material Reduction of Royalty Financing Obligation
2026-08-31 20:05 · Yahoo
Kyntra Bio (KYNB) Q2 2026 Earnings Call Transcript
2026-08-20 21:43 · Yahoo
Kyntra Bio Inc (KYNB) (Q2 2026) Earnings Call Highlights: Advancing FG-3246 and Roxadustat with ...
2026-08-17 19:02 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.